Grady Jason

SEC Form 4 insider trading activity

Grady Jason has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 25, 2026.

On the most recent filing, Grady Jason is listed as Director at IMPACT BIOMEDICAL INC. Inside the rolling window, Grady Jason reported no open-market purchases and 1 open-market sale totaling $33K in IBO.

Companies traded

Other insiders at IBO

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$33K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
IBO
Grady Jason
Sale$33KMar 25SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Grady Jason made?

Grady Jason has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Grady Jason trade?

Grady Jason has filed SEC Form 4 disclosures for 1 company, including IBO.

When was Grady Jason's most recent SEC Form 4 filing?

Grady Jason's most recent SEC Form 4 filing on Tracefour is dated Mar 25, 2026.

What is Grady Jason's total buy and sell value in the current window?

Inside the rolling retention window, Grady Jason bought $0 and sold $33K based on SEC Form 4 filings.

What was Grady Jason's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 50,000 IBO shares on 2026-03-23, worth $33K, per SEC Form 4 filings.